Astrocytic tumors

Zhu, A., Shaeffer, J., Leshe, S., Kolm, P., and El-Mahdi, A.M., 1996, Epidermal growth factor receptor an independent predictor of survival in astrocytic tumors given definitive irradiation, Int.J.Radiat. Oncol.Biol.Phys. 34 809-815. [Pg.186]

Lapointe, M., Lanthier, J., Moumdjian, R., Regina, A., and Desrosiers, R. R. (2005). Expression and activity of L-isoaspartyl methyltransferase decrease in stage progression of human astrocyte tumors. Mol. Brain Res. 135, 93-103. [Pg.144]

Astrocytic tumor Barrett s adenocarcinoma Bladder carcinoma Breast carcinoma... [Pg.298]

Beppu T, Inoue T, Shibata Y, Kurose A, Arai H, Ogasawara K, Ogawa A, Nakamura S, Kabasawa H (2003) Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol 63 109-116. [Pg.761]

Yoshime T, Maruno M, Kumura E, et al. Stochastic determination of the chromosomal region responsible for expression of human glial fibrillary acidic protein in astrocytic tumors. Neu-rosci Lett. 1998 247 29-32. [Pg.124]

CD56 (also known as neural cell adhesion molecule) is expressed on the cell surface of a number of different tissues including natural killer cells, glial and neurons. This antigen may be demonstrated on monocytic and myeloid leukemias, plasma cell dyscrasias, natural killer cell lesions, neural and astrocytic tumors as well as tumors with neuroendocrine differentiation. Antigen density on hematopoietic tumors tends to be at a lower level than on non-hematopoietic lesions and the validation with flow cytometry determination for this antigen is recommended. [Pg.167]

Takekawa Y, Sawada T. Vascular endothelial growth factor and neovascularization in astrocytic tumors. Pathol Int. 1998 48 109-114. [Pg.886]

Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M et al. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 2005 11 8304-8311. [Pg.514]

Iwata, S., Nakagawa, K., Harada, H., Oka, Y., Kumon, Y, and Sakaki, S. (1999). Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurg. 45(1), 24-28 discussion 29. [Pg.35]

Biber K, Zuurman MW, Dijkstra IM, Boddeke HW (2002) Chemokines in the brain neuroimmunology and beyond. Curr Opin Pharmacol 2 63-68 Blasko 1, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B (2000) Costimulatory effects of interferon-gamma and interleukin-1 beta or tumor necrosis factor alpha on the synthesis of Abetal-40 and Abetal-42 by human astrocytes. Neurobiol Dis 7 682-689... [Pg.291]

Domercq M, BrambiUa L, PUati E, Marchalaud J, Volterra A, Bezzi P (2006) P2Y1 receptor-evoked glutamate exocytosis from astrocytes coutrol by tumor uecrosis factor-alpha aud prostaglaudius. J Biol Chem 281 30684-30696... [Pg.292]

Liu IS, lohn GR, Sikora A, Lee SC, Brosnan CF (2000) Modulation of interleukin-1 beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. 1 Neurosci 20 5292-5299... [Pg.295]

Rossi D, BrambiUa L, Valori CF, Crugnola A, Giaccone G, Capobianco R, Mangier M, Kingston AE, Bloc A, Bezzi P, Volterra A (2005) Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J Biol Chem 280 42088-42096... [Pg.298]

Luo Y, Berman MA, Abromson-Leeman SR, Dorf ME (2003) Tumor necrosis factor is required for RANTES-induced astrocyte monocyte chemoattractant protein-1 production. Glia 43 119-127 Machelska H, Stein C (2006) Leukocyte-derived opioid peptides and inhibition of pain. J Neuroimmune Pharmacol 1 90-97... [Pg.372]

Pulliam L, West D, Haigwood N, Swanson RA (1993) HIV-1 envelope gpl20 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses 9 439 44 Pulliam L, Zhou M, Stubblebine M, Bitler CM (1998) Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J Neurosci Res 54 530-538... [Pg.374]

CYP3A mRNA in normal human brain demonstrated by RT-PCR (McFadyen et al., 1998). CYP3A in tumor cells, neurons in normal brain astrocytes were negative by IHC (Kirches et al., 1999). [Pg.61]

Representative photomicrographs of neuronal immunostaining with antibodies recognizing neuron specific enolase (a) and tumor necrosis factor alpha (b) in vitro (c) and ex vivo (d) immunostaining of astrocytes with antibodies recognizing glial fibrillary acidic protein microglial cells with ED-1 (e) and OX-42 (f) antibodies... [Pg.200]

In humans methylene chloride exposure has been associated with a wide variety of cancers in a number of cohort and case control studies pancreatic, prostate, lung, liver, cervical, breast, and astrocytic brain tumors have been reported. Limitations in these studies include small sample size, incomplete exposure information, and concomitant exposure to other carcinogenic substances. The lARC has stated that there is not a sufficiently consistent elevation of risk across studies to make a causal interpretation credible. In a recent study of 1473 workers, followed for nearly 50 years, methylene chloride exposure level was not related to mortality due to all causes, malignant neoplasms, or lung and pancreatic cancers. ... [Pg.472]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...